FDA Rebuffs Bid to Loosen Oversight of AI Radiology Software, Locking In Premarket Review
A new FDA final order taking effect September 17 keeps AI-enabled radiology tools — including cancer-detection and urgent-finding alert software — subject to full 510(k) premarket clearance, formally rejecting a bid by Harrison.ai to exempt certain products from review.